Ms. O'Hara To Offer Guidance, Content Focused on Meeting The Health Care Needs of Canada's Aging Population
TORONTO, March 13, 2019 /CNW/ - Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM) (OTCPK: CANVF), a leading digital cannabis education and analytics company, is pleased to announce the newest addition to its Medical Advisory Board, providing independent medical oversight and original content for the Cannvas.Me digital cannabis education platform. Aislin O'Hara joins the Board bringing with her a wealth of experience and expertise in engaging audiences of older adults 55+ years old and a vast network of partner organizations with whom she has worked closely over her career in the public sector.
"We are delighted to welcome Aislin to our Medical Advisory Board and are confident her deep knowledge of the Canadian seniors' market will greatly enhance our educational offering to older adult audiences curious about cannabis as an alternative to traditional pharmaceuticals," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "Seniors are an overlooked and underserved market, but with Aislin's experience Cannvas plans on leading the cannabis education industry in creating specialized content to address their health care concerns and needs and help explore whether they could benefit from using cannabis, with no pressure to purchase or consume."
A Certified Professional Consultant on Aging (CPCA), Ms. O'Hara spent 12 years supporting seniors' initiatives within the public sector, where she established herself as a trusted professional among seniors' services and support agencies. Among her recent positions was Project Lead - Customer Experience for the Toronto Transit Commission's Wheel-Trans program, whose customer base is vastly comprised of seniors with disabilities. In 2018, she founded O'Hara & Associates Consulting Inc. to provide advice and consultation to businesses and services on how to appropriately serve Canadian seniors and put them at the forefront of strategies and market growth plans.
Among her notable accomplishments, Ms. O'Hara helped develop the 2017 and 2018 Toronto Seniors Strategy and the Toronto HomeShare Pilot (in partnership with the National Initiative of Care for the Elderly). She maintains professional affiliations with a number of senior-focused organizations including the Age-Friendly Business Alliance, among others.
"It's exciting to have Aislin join the Medical Advisory Board and offer her guidance in directing the form and content of our learning modules to better serve an increasingly substantial portion of Canada's population and ensure our seniors have access to reliable and accurate cannabis education addressing issues of importance to their community," said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. "Having Aislin contribute to facilitating cannabis education focused on Canadians 55+ years old strengthens our mission to have Cannvas become the household name for cannabis education and we look forward to a successful collaborative relationship with her as a Board member."
According to Statistics Canada, the number of Canadian seniors by 2021 is projected to exceed the number of children aged 14 and younger for the first time ever. By 2036, the number of seniors could reach between 9.9 and 10.9 million people. Research indicates seniors are turning to cannabis as another tool to better manage their health. However, while cannabis use among older adults continues to increase, education specific to their demographic has not caught up and remains hard to find and difficult to access. With the appointment of Ms. O'Hara, Cannvas is demonstrating its proactive approach in crafting and making available senior-centric cannabis education.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: email@example.com or visit cannvasmedtech.com